# clm_2D8F2FC9E463

subject: Amgen (/record/amgen.md)  
predicate: cash_and_equivalents  
value: 9,741,000,000 United States dollar  
valid_from: 2018-03-31  
valid_to: 2018-06-30  
published: 2018-04-25  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0DBEED486A33  
last_updated: 2026-11-08  
cite: AsOf. "Amgen cash and equivalents: 9,741,000,000 United States dollar", as of 2018-03-31 (until 2018-06-30). Claim clm_2D8F2FC9E463, https://asof.is/claim/clm_2D8F2FC9E463, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815418000008/0000318154-18-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-04-25  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815418000008/0000318154-18-000008-index.htm (primary, SEC EDGAR 10-Q Q1 FY2018, published 2018-04-25)

## Supersedes

- [Amgen](/record/amgen.md) | cash_and_equivalents | 3,800,000,000 United States dollar | valid 2017-12-31 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_2D8F2FC9E463](/claim/clm_2D8F2FC9E463.md) | [clm_16369A4AC42E](/claim/clm_16369A4AC42E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.